Condition
Diffuse Astrocytoma, IDH-Mutant clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Diffuse Astrocytoma, IDH-Mutant clinical trials that are recruiting, at sites in 2 countries (most in Norway (1), United States (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Testing NEO212 for treating certain brain tumors and metastases
This study is testing a new treatment called NEO212 for people with certain types of brain tumors to see if it is safe and effective when combined with standard treatments.
-
Comparing proton and photon therapy for IDH-mutated gliomas
This study tests whether proton therapy can be as effective as traditional photon therapy for people with certain types of brain tumors while possibly improving their quality of life.
Related topics
Quick answers
How many Diffuse Astrocytoma, IDH-Mutant clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Norway (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.